Vor Biopharma logo

Vor Biopharma Share Price Today

(NASDAQ: VOR)

Vor Biopharma share price is $1.39 & ₹121.06 as on 5 Feb 2025, 2.30 'hrs' IST

$1.39

0.05

(3.73%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Vor Biopharma share price in Dollar and Rupees. Guide to invest in Vor Biopharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vor Biopharma, along with analyst recommendations, forecasts, and comprehensive financials.

Vor Biopharma share price movements

  • Today's Low: $1.34
    Today's High: $1.42

    Day's Volatility :5.99%

  • 52 Weeks Low: $0.63
    52 Weeks High: $2.43

    52 Weeks Volatility :74.07%

Vor Biopharma (VOR) Returns

PeriodVor Biopharma IncSector (Health Care)Index (Russel 2000)
3 Months
61.63%
-0.5%
0.0%
6 Months
69.51%
0.1%
0.0%
1 Year
-40.09%
3.2%
0.0%
3 Years
-83.07%
11.1%
-11.7%

Vor Biopharma (VOR) Key Statistics

in dollars & INR

Previous Close
$1.34
Open
$1.35
Today's High
$1.42
Today's Low
$1.335
Market Capitalization
$167.2M
Today's Volume
$254.9K
52 Week High
$2.43
52 Week Low
$0.63
Revenue TTM
$0.0
EBITDA
$-121.2M
Earnings Per Share (EPS)
$-1.64
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-78.07%

How to invest in Vor Biopharma Stock (VOR) from India?

It is very easy for Indian residents to invest directly in Vor Biopharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vor Biopharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vor Biopharma or VOR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vor Biopharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vor Biopharma shares which would translate to 0.627 fractional shares of Vor Biopharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vor Biopharma, in just a few clicks!

Returns in Vor Biopharma (VOR) for Indian investors in Rupees

The Vor Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vor Biopharma investment value today

Current value as on today

₹64,817

Returns

₹35,183

(-35.18%)

Returns from Vor Biopharma Stock

₹40,086 (-40.09%)

Dollar Returns

₹4,903 (+4.9%)

Indian investors sentiment towards Vor Biopharma (VOR)

-40%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Vor Biopharma Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vor Biopharma

  • RA Capital Management, LLC

    18.23%

  • FMR Inc

    5.67%

  • 5AM Venture Management, LLC

    5.10%

  • Hudson Bay Capital Management LP

    1.98%

  • Vanguard Group Inc

    1.57%

  • COWEN AND COMPANY, LLC

    0.98%

Analyst Recommendation on Vor Biopharma

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Vor Biopharma(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Vor Biopharma Stock (VOR)

What analysts predicted

Upside of 747.89%

Target:

$11.79

Current:

$1.39

Insights on Vor Biopharma Stock (Ticker Symbol: VOR)

  • Price Movement

    In the last 3 months, VOR stock has moved up by 78.2%
  • VOR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 96.7%
  • VOR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 86.4% return, outperforming this stock by 168.9%

Vor Biopharma Technicals Summary

Sell

Neutral

Buy

Vor Biopharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Vor Biopharma (VOR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vor Biopharma Inc logo
-20.11%
69.51%
-40.09%
-83.07%
-93.24%
Biontech Se logo
-2.55%
47.81%
22.02%
-32.21%
279.34%
Regeneron Pharmaceuticals, Inc. logo
-2.68%
-34.72%
-25.67%
12.0%
82.54%
Vertex Pharmaceuticals Incorporated logo
19.82%
3.52%
15.9%
98.26%
100.9%
Alnylam Pharmaceuticals, Inc. logo
16.23%
4.16%
57.39%
82.31%
115.97%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vor Biopharma Inc logo
NA
NA
NA
-1.46
-0.78
-0.4
NA
2.22
Biontech Se logo
160.8
NA
0.04
-3.37
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.49
16.49
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vor Biopharma Inc logo
Buy
$167.2M
-93.24%
NA
0.0%
Biontech Se logo
Buy
$28.7B
279.34%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.3B
82.54%
16.49
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.1B
100.9%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.4B
115.97%
NA
-15.86%

About Vor Biopharma

Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC) product candidate that is in phase 1/2 trial to treat acute myeloid leukemia (AML) and other hematological malignancies. The company is also developing Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, which are under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system that is under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, which are under preclinical studies for the treatment of AML. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Organization
Vor Biopharma
Employees
168
CEO
Dr. Robert Ang M.B.A., M.D., MBBS
Industry
Services

Management People of Vor Biopharma

NameTitle
Dr. Robert Ang M.B.A., M.D., MBBS
President, CEO & Director
Dr. Tirtha Chakraborty Ph.D.
Chief Scientific Officer
Dr. Eyal C. Attar M.D.
Chief Medical Officer
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.
Scientific Founder & Chairman of Scientific Advisory Board
Dr. Han Choi M.D.
Chief Financial Officer
Ms. Amy Quinlan
Interim Principal Accounting Officer
Ms. Tania Philipp
Chief People Officer
Mr. John C. King M.B.A.
Chief Commercial Officer & Head of Business Development
Mr. Samir Vattompadam M.S.
Senior Vice President of Portfolio Strategy & Program Management
Mr. David Phillips M.B.A.
Senior VP & Head of Quality

Important FAQs about investing in VOR Stock from India :

What is Vor Biopharma share price today?

Vor Biopharma share price today stands at $1.39, Open: $1.35 ; Previous Close: $1.34 ; High: $1.42 ; Low: $1.34 ; 52 Week High: $2.43 ; 52 Week Low: $0.63.

The stock opens at $1.35, after a previous close of $1.34. The stock reached a daily high of $1.42 and a low of $1.34, with a 52-week high of $2.43 and a 52-week low of $0.63.

Can Indians buy Vor Biopharma shares?

Yes, Indians can invest in the Vor Biopharma (VOR) from India.

With INDmoney, you can buy Vor Biopharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vor Biopharma at zero transaction cost.

How can I buy Vor Biopharma shares from India?

It is very easy to buy Vor Biopharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vor Biopharma (VOR) be purchased?

Yes, you can buy fractional shares of Vor Biopharma with INDmoney app.

What are the documents required to start investing in Vor Biopharma stocks?

To start investing in Vor Biopharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vor Biopharma Stock (VOR)?

Today’s highest price of Vor Biopharma (VOR) is $1.42.

Today’s lowest price of Vor Biopharma (VOR) is $1.34.

What is today's market capitalisation of Vor Biopharma?

Today's market capitalisation of Vor Biopharma VOR is 167.2M

What is the 52 Week High and Low Range of Vor Biopharma Stock (VOR)?

  • 52 Week High

    $2.43

  • 52 Week Low

    $0.63

What are the historical returns of Vor Biopharma (VOR)?

  • 1 Month Returns

    -20.11%

  • 3 Months Returns

    69.51%

  • 1 Year Returns

    -40.09%

  • 5 Years Returns

    -93.24%

Who is the Chief Executive Officer (CEO) of Vor Biopharma ?

Dr. Robert Ang M.B.A., M.D., MBBS is the current Chief Executive Officer (CEO) of Vor Biopharma.